2294P Whole genome sequencing to define the germline-somatic interaction in young-onset lung cancer
Jaclyn LoPiccolo(Harvard University), Pasi A. Jänne(Harvard University), A.J. Pangilinan(Dana-Farber Cancer Institute), Tom Nguyen(Cho Ray Hospital), С. А. Гусев(Skolkovo Institute of Science and Technology), Diane R. Koeller(Dana-Farber Cancer Institute), E. Voligny(Dana-Farber Cancer Institute), Rory Collins(University of Oxford), David C. Christiani(Harvard University), Alicia Pollaci(Dana-Farber Cancer Institute), Li Su(University of Cambridge), Judy E. Garber(Dana-Farber Cancer Institute), Xiaofeng Wang(Virginia Tech), Jianchang Lin(Millennium Engineering and Integration (United States))
Cited by 0
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k